1 results about "Histidine Hydrochloride" patented technology

The present invention relates to a stable secukinumab injection, characterized in that it comprises 50-250 mg / ml of secukinumab, 5-50 mmol / l of histidine and histidine hydrochloride, 5-40 mmol / l of methionine, 150-370 mmol / l of low molecular weight sugar alcohol and polysorbate 80 at 0.01%-0.02% (v / v), in water for injection, pH 5.0-7.0, wherein the low molecular weight sugar alcohol is xylitol.